HBK Investments’s Cardinal Health CAH Stock Holding History

HBK Investments’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,600	Closed	-$240K	–	629
2020 Q2	$240K	Buy	+4,600	New	+$237K	﹤0.01%	515

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HBK Investments's CAH Position: Q1 2021 in Review

HBK Investments sold out of Cardinal Health (CAH) in Q1 2021, closing a stake of 4,598 shares — an estimated $246K sold.

HBK Investments first reported a position in CAH in Q2 2013 and held it in 19 quarters. The position peaked at $18.9M in Q4 2013. 802 funds tracked by Wall St. Rank hold CAH as of Q1 2021.

HBK Investments reported no remaining Cardinal Health position as of Q1 2021 after selling out during the quarter.
HBK Investments sold 4,598 Cardinal Health shares in Q1 2021, an estimated $246K.
HBK Investments first reported a position in Cardinal Health in Q2 2013 and held it in 19 quarters.
HBK Investments's Cardinal Health position peaked at $18.9M in Q4 2013.
802 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2021.

Based on HBK Investments's 13F filing for Q1 2021, filed 17 May 2021.